Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII

European Journal of Clinical Investigation

Volumn 29, Issue 5, 1999, Pages 387-394

  Gottrand, F ^a   Beghin, L ^a   Duhal, N ^b,c   Lacroix, B ^b,c   Bonte, J P ^b,c   Fruchart, J C ^a   Luc, G ^a,d  

^a INSTITUT PASTEUR DE LILLE   (France)

^b Lille Nord of France University   (France)

^c UNIV LILLE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Alcohol; Apolipoprotein AI; Apolipoprotein AII; High density lipoprotein; Kinetic study; Stable isotopes

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CATABOLISM; CHOLESTEROL BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; ISOTOPE LABELING; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WINE;

ADULT; ALCOHOL DRINKING; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, HDL; CROSS-OVER STUDIES; GAMMA-GLUTAMYLTRANSFERASE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LEUCINE; LIPOPROTEIN(A); LIPOPROTEINS, VLDL; MALE; TRIGLYCERIDES; WINE;

EID: 0032920513     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00484.x     Document Type: Article

References (49)

1. 1 Jackson R, Beaglehole R. The relationship between alcohol and coronary heart disease: is there a protective effect? Curr Opin Lipidol, 1993; 4: 21-6.
2. 2 Camargo CA Jr, Williams PT, Vranizan KM, Albers JJ, Wood PD. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. A controlled study. JAMA 1985; 253: 2854-7.
3. 3 Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992; 85: 910-5.
4. 4 Suh I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. The Multiple Risk Factor Intervention Trial Research Group (see comments). Ann Intern Med 1992; 116: 881-7.
5. 5 Valimaki M, Laitinen K, Ylikahri R, et al. The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a). Metabolism 1991; 40: 1168-72.
6. 6 Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits? Br Med J 1996; 312: 731-6.
7. 7 Jackson R, Scragg R, Beaglehole R. Alcohol consumption and risk of coronary heart disease. Br Med J 1991; 303: 211-6.
8. 8 Criqui MH, Cowan LD, Tyroler HA, et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results from the Lipid Research Clinics follow-up study. Am J Epidemiol 1987; 126: 629-37.
9. 9 Razay G, Heaton KW, Bolton CH, Hughes AO. Alcohol consumption and its relation to cardiovascular risk factors in British women. Br Med J 1992; 304: 80-3.
10. 10 Castelli WP, Doyle JT, Gordon T, et al. HDL cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation 1977; 55: 767-72.
11. 11 Gordon T, Castelli WP, Hjortland MC, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707-14.
12. 12 Patsch W, Sharrett AR, Sorlie PD, Davis CE, Brown SA. The relation of high density lipoprotein cholesterol and its subfractions to apolipoprotein A-I and fasting triglycerides: the role of environmental factors. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1992; 136: 546-57.
13. 13 Masarei JR, Puddey IB, Rouse IL, Lynch WJ, Vandongen R, Beilin LJ. Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects. Atherosclerosis 1986; 60: 79-87.
14. 14 Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem 1984; 259: 12201-9.
15. 15 Malmendier CL, Delcroix C. Effect of alcohol intake on high and low density lipoprotein metabolism in healthy volunteers. Clin Chim Acta 1985; 152: 281-8.
16. 16 Fruchart JC, Fievet C, Puchois P. Apolioproteins. Metabolites III: Lipids, amino acids and related compounds. In: Bergmeyer HV, editor. Methods in enzymatic analysis. New York: VCH Publications; 1985; 128-38.
17. 17 Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem 1990; 36: 1431-5.
18. 18 Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-53.
19. 19 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
20. 20 Cobelli C, Toffolo G, Foster DM. Tracer to tracee ratio for analysis of stable tracer data: link with radioactive kinetic formalism. Am J Physiol 1992; 262: E968-E975.
21. 21 Reeds PJ, Hachey DL, Patterson BW, Motil KJ, Klein PD. VLDL apolipoprotein B-100, a potential indicator of the isotopic labeling of the hepatic protein synthetic precursor pool in humans: studies with multiple stable isotopically labeled amino acids. J Nutr 1992; 122: 457-66.
22. 22 Cushman P Jr, Barboriak J, Kalbfleisch J. Alcohol: high density lipoproteins, apolipoproteins. Alcohol Clin Exp Res 1986; 10: 154-7.
23. 23 Contaldo F, D'Arrigo E, Carandente V, et al. Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal men. Metabolism 1989; 38: 166-71.
24. 24 Couzigou P, Fleury B, Crockett R, et al. High density lipoprotein cholesterol and apoprotein A1 in healthy volunteers during long-term moderate alcohol intake. Ann Nutr Metab 1984; 28: 377-84.
25. 25 Moore RD, Smith CR, Kwiterovich PO, Pearson TA. Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B. Am J Med 1988; 84: 884-90.
26. 26 Fraser GE, Andersen JT, Foster N, Goldberg R, Jacobs D, Blackburn H. The effect of alcohol on serum high density lipoprotein (HDL). A controlled experiment. Atherosclerosis 1983; 46: 275-86.
27. 27 Puchois P, Fontan M, Gentilini JL, Gelez P, Fruchart JC. Serum apolipoprotein A-II, a biochemical indicator of alcohol abuse. Clin Chim Acta 1984; 144: 185-9.
28. 28 Valimaki M, Taskinen MR, Ylikahri R, Roine R, Kuusi T, Nikkila EA. Comparison of the effects of two different doses of alcohol on serum lipoproteins, HDL-subfractions and apolipoproteins A-I and A-II. a controlled study. Eur J Clin Invest 1988; 18: 472-80.
29. 29 Rader DJ, Castro G, Zech LA, Fruchart JC, Brewer HB Jr In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. J Lipid Res 1991; 32: 1849-59.
30. 30 Puchois P, Ghalim N, Zylberberg G, Fievet P, Demarquilly C, Fruchart JC. Effect of alcohol intake on human apolipoprotein A-I-containing lipoprotein subfractions. Arch Intern Med 1990; 150: 1638-41.
31. 31 Duhamel G, Nalpas B, Goldstein S, Laplaud PM, Berthelot P, Chapman MJ. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: on the relative roles of alcohol and liver injury. Hepatology 1984; 4: 577-85.
32. 32 Breier C, Lisch HJ, Drexel H, Braunsteiner H. Post-heparin lipolytic activities and alterations of the chemical composition of high density lipoproteins in alcohol-induced type V hyperlipidemia. Atherosclerosis 1984; 52: 317-27.
33. 33 Brinton EA, Eisenberg S, Breslow JL. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J Clin Invest 1989; 84: 262-9.
34. 34 Gylling H, Vega GL, Grundy SM. Physiologic mechanisms for reduced apolipoprotein A-I concentrations associated with low levels of high density lipoprotein cholesterol in patients with normal plasma lipids. J Lipid Res 1992; 33: 1527-39.
35. 35 Ikewaki K, Zech LA, Kindt M, Brewer HB, Rader DJ. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I: a-II in normolipidemic humans. Arterioscler Thromb Vasc Biol 1995; 15: 306-12.
36. 36 Brinton EA. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler Thromb Vasc Biol 1996; 16: 431-40.
37. 37 Ikewaki K, Zech LA, Brewer HB, Rader DJ. ApoA-II kinetics in humans using endogenous labeling with stable isotopes: Slower turnover of apoA-II compared with the exogenous radiotracer method. J Lipid Res 1996; 37: 399-407.
38. 38 Nishiwaki M, Ishikawa T, Ito T, et al. Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin: cholesterol acyltransferase in high-density lipoprotein cholesterol elevation. Atherosclerosis 1994; 111: 99-109.
39. 39 Sillanaukee P, Koivula T, Jokela H, Myllyharju H, Seppa K. Relationship of alcohol consumption to changes in HDL-subfractions. Eur J Clin Invest 1993; 23: 486-91.
40. 40 Williams PT, Krauss RM, Wood PD, Albers JJ, Dreon D, Ellsworth N. Associations of diet and alcohol intake with high-density lipoprotein subclasses. Metabolism 1985; 34: 524-30.
41. 41 Haskell WL, Camargo C, Williams PT, et al. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. N Engl J Med 1984; 310: 805-10.
42. 42 Nestruck AC, Niedmann PD, Wieland H, Seidel D. Chromatofocusing of human high density lipoproteins and isolation of lipoproteins A and A-I. Biochim Biophys Acta 1983; 753: 65-73.
43. 43 Atmeh RF, Shepherd J, Packard CJ. Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy. Biochim Biophys Acta 1983; 751: 175-88.
44. 44 Cohn JS, Wagner DA, Cohn SD, Millar JS, Schaefer EJ. Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J Clin Invest 1990; 85: 804-11.
45. 45 Emmerich J, Verges B, Tauveron I, et al. Familial HDL deficiency due to marked hypercatabolism of normal apoA-I. Arterioscler Thromb 1993; 13: 1299-306.
46. 46 Eggerman TL, Hoeg JM, Meng MS, Tombragel A, Bojanovski D, Brewer HB. Differential tissue-specific expression of human apoA-I and apoA-II. J Lipid Res 1991; 32: 821-8.
47. 47 Ikewaki K, Rader DJ, Schaefer JR, Fairwell T, Zech LA, Brewer HB. Evaluation of apo A-I kinetics in humans using simultaneous stable isotope and exogenous radiotracer methods. J Lipid Res 1993; 34: 2207-15.
48. 48 Hannuksela ML, Liinamaa MJ, Kesaniemi YA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 1994; 110: 35-44.
49. 49 Fumeron F, Betoulle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96: 1664-71.